CN112535283A - Total nutrient formula powder - Google Patents
Total nutrient formula powder Download PDFInfo
- Publication number
- CN112535283A CN112535283A CN202011388124.3A CN202011388124A CN112535283A CN 112535283 A CN112535283 A CN 112535283A CN 202011388124 A CN202011388124 A CN 202011388124A CN 112535283 A CN112535283 A CN 112535283A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- microcapsule powder
- vitamin
- maltodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 218
- 235000015097 nutrients Nutrition 0.000 title abstract description 58
- 239000011812 mixed powder Substances 0.000 claims abstract description 89
- 239000006041 probiotic Substances 0.000 claims abstract description 68
- 235000018291 probiotics Nutrition 0.000 claims abstract description 68
- 230000000529 probiotic effect Effects 0.000 claims abstract description 65
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 63
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 63
- 235000021119 whey protein Nutrition 0.000 claims abstract description 63
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 56
- 235000010755 mineral Nutrition 0.000 claims abstract description 56
- 239000011707 mineral Substances 0.000 claims abstract description 56
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 51
- 230000007062 hydrolysis Effects 0.000 claims abstract description 23
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 235000016709 nutrition Nutrition 0.000 claims abstract description 19
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 14
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 14
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 14
- 241001134770 Bifidobacterium animalis Species 0.000 claims abstract description 13
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 13
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 13
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 13
- 229940118852 bifidobacterium animalis Drugs 0.000 claims abstract description 13
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 13
- 239000003094 microcapsule Substances 0.000 claims description 135
- 229920002774 Maltodextrin Polymers 0.000 claims description 70
- 239000005913 Maltodextrin Substances 0.000 claims description 70
- 229940035034 maltodextrin Drugs 0.000 claims description 70
- 235000021388 linseed oil Nutrition 0.000 claims description 42
- 239000000944 linseed oil Substances 0.000 claims description 42
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 42
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical group OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 38
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 38
- 235000020238 sunflower seed Nutrition 0.000 claims description 26
- 239000003921 oil Substances 0.000 claims description 25
- 235000019198 oils Nutrition 0.000 claims description 25
- 235000021323 fish oil Nutrition 0.000 claims description 23
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 18
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 17
- 239000003813 safflower oil Substances 0.000 claims description 17
- 235000019197 fats Nutrition 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 11
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 10
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 6
- 239000011666 cyanocobalamin Substances 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 239000011772 phylloquinone Substances 0.000 claims description 6
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 6
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 6
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 6
- 235000019192 riboflavin Nutrition 0.000 claims description 6
- 239000002151 riboflavin Substances 0.000 claims description 6
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 6
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 6
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- RZALONVQKUWRRY-FYZOBXCZSA-N 2,3-dihydroxybutanedioic acid;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound OC(=O)C(O)C(O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O RZALONVQKUWRRY-FYZOBXCZSA-N 0.000 claims description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 5
- 235000019486 Sunflower oil Nutrition 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- 229960004874 choline bitartrate Drugs 0.000 claims description 5
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 claims description 5
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 5
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 claims description 5
- 229960003966 nicotinamide Drugs 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 5
- 239000011570 nicotinamide Substances 0.000 claims description 5
- 229960000342 retinol acetate Drugs 0.000 claims description 5
- 235000019173 retinyl acetate Nutrition 0.000 claims description 5
- 239000011770 retinyl acetate Substances 0.000 claims description 5
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 5
- 229960005055 sodium ascorbate Drugs 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 5
- 239000002600 sunflower oil Substances 0.000 claims description 5
- 229960003080 taurine Drugs 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 239000011665 D-biotin Substances 0.000 claims description 4
- 235000000638 D-biotin Nutrition 0.000 claims description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 4
- 239000011781 sodium selenite Substances 0.000 claims description 4
- 235000015921 sodium selenite Nutrition 0.000 claims description 4
- 229960001471 sodium selenite Drugs 0.000 claims description 4
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 claims description 4
- 229940118149 zinc sulfate monohydrate Drugs 0.000 claims description 4
- RNZCSKGULNFAMC-UHFFFAOYSA-L zinc;hydrogen sulfate;hydroxide Chemical compound O.[Zn+2].[O-]S([O-])(=O)=O RNZCSKGULNFAMC-UHFFFAOYSA-L 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims description 3
- 239000001259 polydextrose Substances 0.000 claims description 3
- 235000013856 polydextrose Nutrition 0.000 claims description 3
- 229940035035 polydextrose Drugs 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229940068840 d-biotin Drugs 0.000 claims description 2
- 229940057917 medium chain triglycerides Drugs 0.000 claims description 2
- 150000004682 monohydrates Chemical class 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- 229960003975 potassium Drugs 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- PJAHUDTUZRZBKM-UHFFFAOYSA-K potassium citrate monohydrate Chemical compound O.[K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PJAHUDTUZRZBKM-UHFFFAOYSA-K 0.000 claims description 2
- 229940050931 potassium citrate monohydrate Drugs 0.000 claims description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 29
- 238000010521 absorption reaction Methods 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 13
- 201000010538 Lactose Intolerance Diseases 0.000 abstract description 12
- 230000006870 function Effects 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- 235000021245 dietary protein Nutrition 0.000 abstract description 5
- 208000030159 metabolic disease Diseases 0.000 abstract description 4
- 208000010668 atopic eczema Diseases 0.000 abstract description 3
- 230000000172 allergic effect Effects 0.000 abstract description 2
- 238000004806 packaging method and process Methods 0.000 description 35
- 230000000968 intestinal effect Effects 0.000 description 29
- 239000000126 substance Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 238000005303 weighing Methods 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 17
- 241000186000 Bifidobacterium Species 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 241000186660 Lactobacillus Species 0.000 description 9
- 238000011049 filling Methods 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 241000193468 Clostridium perfringens Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 241000588914 Enterobacter Species 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 6
- 230000009931 harmful effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 241000305071 Enterobacterales Species 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 102000007562 Serum Albumin Human genes 0.000 description 4
- 108010071390 Serum Albumin Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 235000007715 potassium iodide Nutrition 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 102000004338 Transferrin Human genes 0.000 description 3
- 108090000901 Transferrin Proteins 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 229960002104 cyanocobalamin Drugs 0.000 description 3
- 235000000639 cyanocobalamin Nutrition 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000003715 nutritional status Nutrition 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 3
- 235000019175 phylloquinone Nutrition 0.000 description 3
- 229960001898 phytomenadione Drugs 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 239000012581 transferrin Substances 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 102000007584 Prealbumin Human genes 0.000 description 2
- 108010071690 Prealbumin Proteins 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 description 1
- 229910000395 dimagnesium phosphate Inorganic materials 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000019138 food restriction Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of food, and particularly relates to total nutrient formula powder, which is suitable for being aged more than or equal to 10 years and comprises the following raw materials in parts by weight: 20-32 parts of hydrolyzed whey protein, 14.5-34 parts of fat, 17-47.5 parts of carbohydrate, 4.5-6.5 parts of dietary fiber, 4-6 parts of mineral premix, 1-3 parts of vitamin premix and 0.5-2 parts of probiotic mixed powder; wherein the hydrolysis degree of the hydrolyzed whey protein is 30-40%; the strains of the probiotic mixed powder comprise bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus. The total nutrient formula powder provided by the invention meets the requirements of people who are limited in eating, have metabolic disorder, have consumption and absorption disorder, are lactose intolerant, have normal gastrointestinal tract functions and are allergic to food protein on comprehensive nutrition under the synergistic effect of the hydrolyzed whey protein, the probiotics and other raw materials by a unique ratio.
Description
Technical Field
The invention belongs to the field of food, and particularly relates to total nutrient formula powder.
Background
The formula food for special medical application is specially processed and prepared for meeting the special requirements of people with limited food intake, digestive absorption disorder, metabolic disorder or specific disease states on nutrients or diet. The product must be eaten alone or in combination with other foods under the guidance of doctors or clinical dieticians. The formula food for special medical application is only one way of providing nutrition support for clinical patients, and provides a selection mode for clinical nutrition support.
At present, people who are suitable for formula foods with special medical purposes are mostly directed to infants and people with specific diseases, such as people with diabetes, liver diseases and the like, but the requirements and the types of nutrition for different ages are different, and the formula foods for infants cannot be suitable for people with gastrointestinal function impairment and digestive function reduction more than 10 years old, so that the determination of the full-nutrition powder suitable for the people with gastrointestinal function impairment and digestive function reduction more than 10 years old is vital.
Disclosure of Invention
The invention provides a total nutrient formula powder, which meets the requirements of people who are limited in eating, disordered in metabolism, have consumption and absorption disorder, are lactose intolerant, have normal gastrointestinal tract functions and are allergic to food protein on comprehensive nutrition by unique proportion under the synergistic effect of raw materials such as hydrolyzed whey protein and probiotics.
The invention provides total nutrient formula powder, which is suitable for being aged more than or equal to 10 years and is characterized by comprising the following raw materials in parts by weight: 20-32 parts of hydrolyzed whey protein, 14.5-34 parts of fat, 17-47.5 parts of carbohydrate, 4.5-6.5 parts of dietary fiber, 4-6 parts of mineral premix, 1-3 parts of vitamin premix and 0.5-2 parts of probiotic mixed powder;
wherein the hydrolysis degree of the hydrolyzed whey protein is 30-40%;
the strains of the probiotic mixed powder comprise bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus.
The deep hydrolyzed whey protein with the hydrolysis degree of 30-40% is added into the total nutrient formula powder, so that adverse reactions such as diarrhea, abdominal pain and the like caused by using whole protein are avoided, and the 30-40% deep hydrolyzed whey protein obtains more absorbable polypeptide and micromolecules and reduces the burden of the gastrointestinal tract; and intestinal flora state is improved by bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus, so that under the synergistic effect of 30-40% of deeply hydrolyzed whey protein and raw materials such as bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus, people with limited eating, metabolic disorder and consumption and absorption disorder of more than 10 years can absorb daily required full nutritional ingredients in the full nutritional formula powder consisting of hydrolyzed whey protein, fat, carbohydrate, dietary fiber, mineral premix, vitamin premix and probiotic mixed powder provided by the invention without the need of supplementing other foods. Furthermore, as the higher the hydrolysis degree of the hydrolyzed whey protein is, the bitter the taste is, the unique proportion of carbohydrate and dietary fiber is adopted in the invention, the taste of the full-nutrition formula powder is adjusted, the sweetness is suitable, no bitter taste exists, and essence, pigment and other additives are not required to be added. The total nutrient formula powder provided by the invention is a low-lactose formula, so that the total nutrient formula powder is suitable for lactose intolerant people over 10 years old, and is suitable for people with normal gastrointestinal tract function but allergy to food protein.
Detailed Description
In order to make the technical problems, technical solutions and advantageous effects to be solved by the present invention more clearly apparent, the present invention is further described in detail below with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
The embodiment of the invention provides total-nutrient formula powder, which is suitable for being aged more than or equal to 10 years and comprises the following raw materials in parts by weight: 20-32 parts of hydrolyzed whey protein, 14.5-34 parts of fat, 17-47.5 parts of carbohydrate, 4.5-6.5 parts of dietary fiber, 4-6 parts of mineral premix, 1-3 parts of vitamin premix and 0.5-2 parts of probiotic mixed powder;
wherein the hydrolysis degree of the hydrolyzed whey protein is 30-40%;
the strains of the probiotic mixed powder comprise bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus.
The total nutrient formula powder provided by the embodiment is added with the deeply hydrolyzed whey protein with the hydrolysis degree of 30-40%, so that adverse reactions such as diarrhea and abdominal pain caused by using whole protein are avoided, the 30-40% of deeply hydrolyzed whey protein obtains more absorbable polypeptide and micromolecular protein and reduces the load of gastrointestinal tracts, the protein is easier to absorb as the higher the hydrolysis degree of the whey protein is, the proportion of molecules smaller than 1000Da in the hydrolyzed whey protein with the hydrolysis degree of about 10% is about 40%, and the proportion of molecules smaller than 1000Da in the hydrolyzed whey protein with the hydrolysis degree of 30% is higher than 80%, so that the deeply hydrolyzed whey protein in the embodiment is more easily absorbed; the intestinal flora state is improved through the bifidobacterium animalis BS01, the lactobacillus rhamnosus LR04 and the lactobacillus acidophilus, the impedance of intestinal tracts to the colonization of external harmful microorganisms is increased, and the intestinal flora is beneficially adjusted, so that the anabolism can be effectively promoted under the synergistic effect of 30-40% of deeply hydrolyzed whey protein and the raw materials of the bifidobacterium animalis BS01, the lactobacillus rhamnosus LR04 and the lactobacillus acidophilus, and the formula powder consisting of the hydrolyzed whey protein, fat, carbohydrate, dietary fiber, mineral substance premix, vitamin premix and probiotic mixed powder, which is limited in eating above 10 years old, disordered in metabolism and impaired in consumption and absorption, can be absorbed by people who consume and absorb the formula powder consisting of the hydrolyzed whey protein, the fat, the carbohydrate, the dietary fiber, the mineral substance premix, the vitamin premix and the probiotic mixed powder, and the nutritional status of. Further, since the hydrolyzed whey protein has higher degree of hydrolysis and bitter taste, the product taste is adjusted by adopting the unique ratio of carbohydrate to dietary fiber in the embodiment, the sweetness is suitable, no bitter taste exists, and no essence, pigment or other additives are added. The total nutrient formula powder provided by the embodiment is a low-lactose formula, so that the total nutrient formula powder provided by the embodiment is suitable for lactose intolerant people over 10 years old, and can be suitable for people with normal gastrointestinal tract function but allergy to food protein.
Further, the degree of hydrolysis of the hydrolyzed whey protein is 34% to 38%. The protein in the hydrolyzed whey protein mainly exists in the form of short peptide or amino acid, is more favorable for intestinal absorption compared with macromolecular protein, has the characteristics of low osmotic pressure, low antigenicity, good intestinal tolerance, direct and balanced absorption, and promotion of the utilization of nutrient substances by intestinal microorganisms and the absorption of amino acids and trace elements, integrally improves the digestion utilization rate of target people (people with food restriction, metabolic disorder, consumption and absorption disturbance, lactose intolerance, normal gastrointestinal tract function but food protein allergy) and corrects negative nitrogen balance, and does not cause gastrointestinal adverse reactions such as allergy, diarrhea and the like of the target people. In the embodiment, the hydrolysis degree of the hydrolyzed whey protein is controlled to be 34-38%, so that the hydrolyzed short peptides and amino acids can be better absorbed, and particularly when the hydrolysis degree of the extensively hydrolyzed whey protein is 38%, the absorption effect of the short peptides and amino acids is best, the allergenicity of the whey protein is obviously reduced, and the growth effect of each strain in the probiotic mixed powder is better.
Further, the ratio of the animal bifidobacterium BS01 to the lactobacillus rhamnosus LR04 to the lactobacillus acidophilus is 1:1:1, the auxiliary material of the probiotic mixed powder is polydextrose, and the number of the live probiotics is 5.0 x 1010And (4) CFU. The unique flora proportion adopted in the probiotic mixed powder provided by the embodiment can effectively increase the number of bifidobacteria and lactobacilli in intestinal tracts of target people, reduce the number of clostridium perfringens, enhance the resistance of the intestinal tracts of the target people to the colonization of external harmful microorganisms, and have beneficial regulation effect on the intestinal flora, and the regulation effect of the probiotic mixed powder provided by the embodiment on the intestinal flora is better than that of single probiotic.
Further, the fat is derived from at least one of sunflower seed oil, safflower seed oil, linseed oil, medium chain triglycerides, and fish oil; the carbohydrate is maltodextrin; the dietary fiber is fructo-oligosaccharide and/or resistant dextrin. In the embodiment, the carbohydrate is maltose, the dietary fiber is fructo-oligosaccharide and/or resistant dextrin, and the ratio of the carbohydrate to the dietary fiber is controlled to be 2.5-10.5, so that the bitterness of the deeply hydrolyzed whey protein can be effectively adjusted, and the obtained total nutrient formula powder has moderate sweetness and no bitterness. Preferably, the dietary fiber in the embodiment is fructo-oligosaccharide, and the probiotic mixed powder consisting of bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus is added into the total nutrient formula powder, so that the proliferation of bifidobacterium animalis can be realized, the absorption of minerals such as Ca and Fe can be promoted, the synthesis of vitamins can be promoted, and when the addition amount of the fructo-oligosaccharide is 4.5-6.5%, the growth effect of the strains in the probiotic mixed powder is better, so that the intestinal flora state of a target population can be adjusted, and the nutritional status of the target population can be improved.
In the above embodiment, sunflower seed oil and safflower seed oil with high linoleic acid content, linseed oil with high linolenic acid content, rapidly energized medium chain triglyceride, and fish oil rich in omega-3 unsaturated fatty acids are used as fat source substances, so that the demand of the target population on the fat substances is ensured, and the health state of the target population is effectively improved.
Further, the following components are included in the fatty substance: 8-15 parts of sunflower seed oil microcapsule powder, 2-5 parts of linseed oil microcapsule powder and 8-14 parts of medium-chain triglyceride microcapsule powder. In this embodiment, the sources of the controlled fat substances are sunflower seed oil, linseed oil and medium-chain triglyceride, if the addition amount of the medium-chain triglyceride is too small, energy cannot be supplied quickly, and if the addition amount of the medium-chain triglyceride is too large, the health state of the target population cannot be guaranteed.
Further, the following components are included in the fatty substance: 8-15 parts of sunflower seed oil microcapsule powder, 2-5 parts of linseed oil microcapsule powder, 4-8 parts of medium-chain triglyceride microcapsule powder and 2-6 parts of fish oil microcapsule powder. The fatty acid proportions in different vegetable oils are different, so that the components of the fatty substances are required to be adjusted according to the requirement of the target population on the total fat content, so that the reasonable amount of linoleic acid, linolenic acid and omega-3 unsaturated fatty acid is provided for the target population while the rapid energy supply is ensured, and the health state of the target population is ensured.
Further, the following components are included in the fatty substance: 8-13 parts of safflower seed oil microcapsule powder, 2.5-5.5 parts of linseed oil microcapsule powder and 8-14 parts of medium-chain triglyceride microcapsule powder. The safflower seed oil is used for providing linoleic acid, and the requirement of target people on the fat content can be met under the proportion of the embodiment.
Further, the following components are included in the fatty substance: 8-13 parts of safflower seed oil microcapsule powder, 2.5-5.5 parts of linseed oil microcapsule powder, 4-8 parts of medium-chain triglyceride microcapsule powder and 2-6 parts of fish oil microcapsule powder. The requirement of target people on the fat amount can be met under the proportion of the embodiment.
Further, the total nutrient formula powder consists of the following components:
36.39% of maltodextrin; 25.04% of hydrolyzed whey protein; 11.824% of sunflower oil microcapsule powder; 2.956% of linseed oil microcapsule powder; 10.56% of medium chain triglyceride microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder. In the embodiment, by controlling the addition amount of each substance, the intestinal state of the target population is effectively improved under the synergistic effect of the hydrolyzed whey protein, the fructo-oligosaccharide and the probiotic mixed powder, the number of bifidobacteria and lactobacilli in the intestinal tract of the target population is increased, the number of clostridium perfringens is reduced, the impedance to external harmful microorganism colonization is increased, and an effective regulation effect on the intestinal flora is achieved. The detection shows that the total nutrient formula powder food provided by the embodiment has protein more than or equal to 18g/100g, fat more than or equal to 13g/100g, linoleic acid energy supply ratio more than or equal to 4%, linolenic acid energy supply ratio more than or equal to 0.8% and carbohydrate more than or equal to 50; the vitamins and minerals all meet the requirements of special medical application formula food in the national standard of GB 29922 food safety.
The fat providing substance was improved over the above examples, wherein the maltodextrin was 36.39%; 25.04% of hydrolyzed whey protein; 11.824% of sunflower oil microcapsule powder; 2.956% of linseed oil microcapsule powder; 5.56% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder; in the embodiment, the health state of the target population can be ensured while the intestinal state of the target population can be improved.
The fat providing substance was improved over the above examples, wherein the maltodextrin was 36.39%; 25.04% of hydrolyzed whey protein; 10.824% of safflower seed oil microcapsule powder; 3.956% of linseed oil microcapsule powder; 10.56% of medium chain triglyceride microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder. In the embodiment, the health state of the target population can be ensured while the intestinal state of the target population can be improved.
The fat providing substance was improved over the above examples, with 36.39% maltodextrin; 25.04% of hydrolyzed whey protein; 10.824% of safflower seed oil microcapsule powder; 3.956% of linseed oil microcapsule powder; 5.56% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder. In the embodiment, the health state of the target population can be ensured while the intestinal state of the target population can be improved.
Further, the total nutrient formula powder consists of the following components: 47.5% of maltodextrin; hydrolyzed whey protein 20%; 8% of sunflower seed oil microcapsule powder; 5% of linseed oil microcapsule powder; 8% of medium chain triglyceride microcapsule powder; 4.5 percent of fructo-oligosaccharide; 4% of mineral premix; 1% of vitamin premix; 2% of probiotic mixed powder. Through the research on the required amount of the nutrient substances and various nutrient substances needed by the target population, the proportion of each substance in the embodiment is determined, and under the proportion of the various substances provided by the embodiment, the intestinal state of the target population can be effectively improved, so that the target population can better absorb various nutrient substances, and the health state of the target population is ensured.
Further, the total nutrient formula powder consists of the following components: 17% of maltodextrin; 32% of hydrolyzed whey protein; 15% of sunflower seed oil microcapsule powder; 5% of linseed oil microcapsule powder; 15% of medium chain triglyceride microcapsule powder; 6.5 percent of fructo-oligosaccharide; 6% of mineral premix; 3% of vitamin premix; 0.5 percent of probiotic mixed powder. Under the proportion of the various materials that this embodiment provided, can effectual improvement target crowd's intestinal state for target crowd can carry out better absorption to various nutrients, has guaranteed target crowd's health.
Further, the total nutrient formula powder consists of the following components: 17% of maltodextrin; 32% of hydrolyzed whey protein; 15% of sunflower seed oil microcapsule powder; 5% of linseed oil microcapsule powder; 14% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 4.5 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1% of vitamin premix; 1% of probiotic mixed powder. Under the proportion of the various materials that this embodiment provided, can effectual improvement target crowd's intestinal state for target crowd can carry out better absorption to various nutrients, has guaranteed target crowd's health.
Further, the total nutrient formula powder consists of the following components: 44.5% of maltodextrin; hydrolyzed whey protein 20%; 8% of sunflower seed oil microcapsule powder; 2% of linseed oil microcapsule powder; 8% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 4.5 percent of fructo-oligosaccharide; 4% of mineral premix; 3% of vitamin premix; 1% of probiotic mixed powder. Under the proportion of the various materials that this embodiment provided, can effectual improvement target crowd's intestinal state for target crowd can carry out better absorption to various nutrients, has guaranteed target crowd's health.
Further, the vitamin premix consists of the following components: maltodextrin 31.7% -68.208%; 20% -39% of choline bitartrate; 3% -10% of inositol; 3% -8% of L-carnitine tartrate; 3.5 to 7.5 percent of sodium ascorbate; 1% -4% of taurine; 0.8% -2.8% of vitamin E (50%); 0.1% -0.9% of nicotinamide; 0.1 to 0.6 percent of vitamin A acetate; 0.05 to 0.5 percent of D-calcium pantothenate; vitamin D3 (cholecalciferol) 0.05% -0.5%; vitamin B12 cyanocobalamin (0.1% in maltodextrin) 0.05% -0.5%; folic acid (10% maltodextrin) 0.05% -0.5%; 0.05% -0.45% of D-biotin (1% in maltodextrin); 0.02% -0.45% of vitamin B1 (thiamine hydrochloride); 0.01% -0.45% of vitamin B6 (pyridoxine hydrochloride); 0.01% -0.45% of vitamin B2 (riboflavin); 0.001% -0.35% of vitamin K1 (5%); potassium iodide (10% in maltodextrin) 0.001% -0.35%.
In the embodiment, after a great deal of research is carried out on the types and the contents of the vitamins required by the target population, the types and the contents of the vitamin premix are determined, and if the contents of certain vitamins are too low to meet the demand of the target population, the target population is required to be matched with other foods for eating, so that the types and the contents of the vitamins provided by the embodiment can meet the demand of the target population on the vitamins and can be well absorbed. Specifically, the vitamin premix comprises the following components: 52.7275% of maltodextrin; 25.6078% of choline bitartrate; 6.3333% of inositol; 4.8851% L-carnitine tartrate; sodium ascorbate 4.2442%; taurine 2.0000%; vitamin E (50%) 1.7880%; 0.4563% of nicotinamide; 0.3282% of vitamin A acetate; 0.2802% of D-calcium pantothenate; vitamin D3 (cholecalciferol) 0.2400%; vitamin B12 cyanocobalamin (0.1% in maltodextrin) 0.2133%; folic acid (10% maltodextrin) 0.2133%; d-biotin (1% in maltodextrin) 0.1887%; vitamin B1 (thiamine hydrochloride) 0.1310%; vitamin B6 (pyridoxine hydrochloride) 0.1220%; vitamin B2 (riboflavin) 0.1000%; vitamin K1 (5%) 0.0800%; 0.0610% potassium iodide (10% in maltodextrin). The variety and the content of the vitamins are reasonably prepared, so that the nutritional density of the total nutrient formula powder can be improved, the requirements of target people on the vitamins can be met, and diseases caused by vitamin deficiency can be reduced and prevented.
Further, the mineral premix consists of the following components: 15% -22% of monopotassium phosphate; 15% -21% of calcium carbonate; 15% -21% of sodium chloride; 1.2% -35.68% of maltodextrin; 10 to 17 percent of magnesium sulfate (dry product); 9% -15% of potassium citrate-monohydrate; potassium pyrophosphate 0.1% -1%; manganese sulfate-water (10% in maltodextrin) 0.08% -0.45%; 0.06% -0.35% of zinc sulfate monohydrate; sodium selenite (1% in maltodextrin) 0.05% -0.6%; 0.03 to 0.4 percent of copper sulfate. In this example, after a great deal of research on the desired mineral content of the target population, the types and contents of the minerals are determined to meet the needs of the target population. Specifically, the mineral premix comprises the following components: potassium dihydrogen phosphate 18.7636; 18.6168% of calcium carbonate; 18.4612% of sodium chloride; 16.4669% of maltodextrin; 13.6567% magnesium sulfate (dried product); potassium citrate-12.7481% monohydrate; 0.4800% of potassium pyrophosphate; 0.2467% manganese sulfate-water (10% in maltodextrin); 0.2395% of zinc sulfate monohydrate; 0.1991% sodium selenite (1% in maltodextrin); 0.1212 percent of copper sulfate and reasonable preparation of the types and the contents of the minerals, meets the requirements of target people on the minerals, does not need to be matched with other foods for eating, and ensures the health status of the target people.
On the other hand, the embodiment of the invention also provides a preparation method of the total nutrient formula powder, which comprises the following steps:
step S10: weighing, namely weighing the raw materials according to the formula amount for later use;
step S20: premixing, namely putting the deeply hydrolyzed whey protein and maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: totally mixing, namely putting materials into a 800L hopper according to the sequence of safflower seed oil microcapsule powder (sunflower safflower seed oil microcapsule powder), fructo-oligosaccharide, vitamin premix, medium-chain triglyceride microcapsule powder and/or fish oil microcapsule powder, mineral premix, linseed oil microcapsule powder and probiotic mixed powder in the premixed powder, and totally mixing for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the qualified total mixed powder in an inner package mode at the packaging machine speed of 10-20 barg/min, and then carrying out outer package to obtain a finished product.
The state, the uniformity and the effect of the finally obtained full-nutrition formula powder are different due to different feeding sequences, the quality of the product can be directly influenced, under the feeding sequence and the preparation conditions of the embodiment, the faint yellow to yellow powder can be obtained, the formula powder which is free of visible foreign impurities, agglomeration, peculiar smell and good in uniformity and has unique flavor can be obtained, the synergistic effect of all substances in the formula powder is good, the intestinal state of a target group is obviously improved, and the requirements of the target group on various nutritional ingredients are met.
The invention is described in further detail with reference to a part of the test results, which are described in detail below with reference to specific examples.
Example 1
The total nutrient formula powder comprises the following components in percentage by mass as shown in table 1:
TABLE 1
Wherein, the vitamin premix comprises the components with the percentage shown in the table 2:
TABLE 2
Name (R) | Content (%) |
Maltodextrin | 52.7275 |
Choline bitartrate | 25.6078 |
Inositol | 6.3333 |
L-carnitine tartrate | 4.8851 |
Ascorbic acid sodium salt | 4.2442 |
Taurine | 2.0000 |
Vitamin E (dl-a-tocopheryl acetate) 50% | 1.7880 |
Nicotinamide | 0.4563 |
Vitamin A acetate 325000IU | 0.3282 |
D-calcium pantothenate | 0.2802 |
Vitamin D3(Cholcidol) 100000IU | 0.2400 |
Vitamin B12Cyanocobalamin (0.1% in maltodextrin) | 0.2133 |
Folic acid (10% maltodextrin) | 0.2133 |
D-Biotin (1% in maltodextrin) | 0.1887 |
Vitamin B1(thiamine hydrochloride) | 0.1310 |
Vitamin B6(pyridoxine hydrochloride) | 0.1220 |
Vitamin B2(Riboflavin) | 0.1000 |
Vitamin K1 5% | 0.0800 |
Potassium iodide (10% in maltodextrin) | 0.0610 |
The mineral premix comprises the components in percentage as shown in table 3:
TABLE 3
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, preparing a mineral premix and a vitamin premix according to the formula shown in tables 2 and 3, and weighing the raw materials according to the formula shown in table 1 for later use;
step S20: premixing, namely putting 25.04 parts of deeply hydrolyzed whey protein (hydrolysis degree of 38%) and 36.39 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: total mixing, namely adding 11.824 parts of sunflower seed oil microcapsule powder, 5.23 parts of fructo-oligosaccharide, 1.5 parts of vitamin premix, 5.56 parts of medium chain triglyceride microcapsule powder, 5 parts of fish oil microcapsule powder, 5.5 parts of mineral premix, 2.956 parts of linseed oil microcapsule powder and 1 part of probiotic mixed powder into the premixed powder in sequence, and then putting the materials into a 800L hopper to be mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
The total nutrient formula powder provided in this example was evaluated: the influence of the total nutrient formula of the embodiment on the immune function of the red blood cells of the mice is evaluated by an animal experiment; clinical tests are utilized to evaluate the special application effect of the total nutrient formula powder on clinically severe patients.
Animal experiment evaluation method: half of Kunming mice (purchased from Beijing Wittiulihua laboratory animal technology Co., Ltd.) with the body weight of 18g-20g are selected and randomly grouped. The administration mode comprises the following steps: and (5) performing intragastric administration. The blank group was given physiological saline, the control group mice were given the ordinary total nutrient formula powder (whole protein probiotic-free formula), and the experimental group mice were given the total nutrient formula powder. The mouse retrobulbar plexus red blood cell (C3b) receptor rosette (E-C3bR), red blood cell immune complex rosette (E-ICR) and tumor red blood cell rosette (T-RR) were tested once a day for seven consecutive days, and the results are shown in Table 4. The formula of the common total nutrient formula powder is as follows: starch sugar (solid glucose syrup), maltodextrin, sunflower seed oil, sodium caseinate, white granulated sugar, calcium caseinate, inulin fructo-oligosaccharide mixture (inulin, fructo-oligosaccharide), soybean oil, soy protein isolate, milk protein isolate, rapeseed oil, vitamin a palmitate, vitamin D3, dl-alpha-tocopherol acetate, mixed tocopherol concentrate, phytomenadione, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamin, nicotinamide, folic acid, D-calcium pantothenate, L-ascorbic acid, ascorbyl palmitate, D-biotin, sodium citrate, sodium chloride, potassium citrate, potassium chloride, copper sulfate, magnesium chloride, magnesium hydrogen phosphate, ferrous sulfate, ferric pyrophosphate, zinc sulfate, manganese sulfate, tricalcium phosphate, potassium iodide, sodium selenate, chromium chloride, sodium molybdate, choline chloride, beta-carotene, phospholipid, flavoring essence and spice (flavoring essence and vanillin), calcium carbonate, dipotassium hydrogen phosphate, L-sodium ascorbate, citric acid and potassium hydroxide.
TABLE 4 Effect of the nutritionally complete formula of this example on the binding rate of the three rosettes
As can be seen from table 4, the total nutrient formula powder of this example has a significant effect of promoting the formation of three rosettes, and is higher than the common total nutrient formula powder (whole protein probiotic-free formula).
And (3) clinical trials: 29 patients with age greater than or equal to 10 age with clinical gastrointestinal absorption dysfunction and malnutrition were selected, and the body weight, serum albumin, transferrin, pre-albumin, creatinine, and serum albumin were measured before, after 15 days of nutritional support and 30 days of nutritional support, respectively, before and after administration of the total nutritional formula powder of this example, and the results of the experiment are shown in table 5:
TABLE 5 patient nutritional support before and after relevant index changes
As can be seen from Table 5, the body weight, serum albumin and creatinine were not significantly changed (p > 0.05) after 15 days of nutritional support, and transferrin and pre-albumin were significantly increased (p < 0.05); after 30 days, the change difference of the body weight and the creatinine is obvious (p is less than 0.05), the change difference of the procalbumin, the transferrin and the serum albumin is obviously increased, and the change difference is extremely obvious (p is less than 0.01) compared with that before the nutrition support, in addition, no vomit, reflux and aspiration occur during the taking period of 29 patients, and the diarrhea of part of the patients with the diarrhea condition is also improved, so the total nutrient formula powder can effectively promote the anabolism and improve the nutrition condition of the patients.
Furthermore, 20 clinical adults with lactose intolerance were selected, and the total nutrient formula powder provided by the embodiment was continuously taken for 30 days, six times a day, and 80g each time. Lactose absorption was evaluated by Hydrogen Breath Test (HBT) and the incidence of abdominal distension, diarrhea, skin eczema was also observed. HBT is positive, which indicates lactose malabsorption, HBT is positive, and lactose intolerance occurs in patients with any symptoms of abdominal distension, abdominal pain and diarrhea, and the experimental results are shown in Table 6:
TABLE 6 comparison of results before and after nutritional support for lactose intolerant patients
Index (I) | Results | p |
HBT | Negative of | <0.01 |
Abdominal distention | Is free of | <0.05 |
Diarrhea (diarrhea) | Is free of | <0.01 |
Abdominal pain | Is free of | <0.05 |
As can be seen from table 6, the HBTs of the subjects were negative and did not develop any symptom of abdominal distension, diarrhea, and abdominal pain, and none of the subjects developed lactose intolerance, so it can be seen that the total nutritional formula powder provided in this example is suitable for lactose intolerant patients.
According to results of animal experiments and clinical tests, the total nutrient formula powder provided by the embodiment can improve the immunity of the organism, improve the nutritional status and avoid lactose intolerance.
Animal evaluation test data of effect of probiotic mixed powder on regulating intestinal flora
Experimental groups: self-made probiotic mixed powder (the ratio of bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus is 1:1:1, and the auxiliary material of the probiotic mixed powder is polydextrose); blank control group: a placebo; positive control group 1: a group of Bifidobacterium animalis; positive control 2 group: lactobacillus acidophilus group; positive control group 3: lactobacillus rhamnosus group.
18 g-22 g male SPF-grade healthy Balb/c mice (purchased from Beijing Wittingle laboratory animal technology Co., Ltd.) are randomly grouped, 10 mice in each group are subjected to intragastric administration for 14d, 0d, 7d and 14d mouse feces are collected, and the number of bifidobacteria, lactobacillus, enterobacteria and clostridium perfringens in the feces and the ratio (B/E value) of the bifidobacteria to the enterobacteria are counted by plate culture after gradient dilution. The results of the experiments are shown in tables 7 to 11:
From table 7, it can be seen that the viable count of bifidobacterium in the intestinal tract of the mouse is changed, and the viable count of bifidobacterium in the intestinal tract of the mouse 7 days after the intervention of the probiotic mixed powder in the experimental group is significantly higher than that in the blank control group (P is less than 0.05), which indicates that the probiotic mixed powder has the effect of increasing the number of bifidobacterium in the intestinal tract of the mouse and the effect is better than that of the positive control group.
From Table 8, it can be seen that the number of live intestinal lactobacilli in mice is changed, and the number of live intestinal lactobacilli in mice of positive control group 2 and positive control group 3 on day 14 is significantly higher than that before the experiment (0d, P < 0.05); on the 7 th day after the intervention of the experimental group, the number of the live lactobacillus is obviously higher than that of the blank control group (P is less than 0.05), which indicates that the probiotic mixed powder of the experimental group has the function of increasing the number of the lactobacillus in the intestinal tract of the mouse, and the effect is better than that of the positive control group.
It can be seen from table 9 that the change of viable bacteria amount of enterobacter intestinal tract of mice, comparison of self change before and after the experiment of viable bacteria amount of enterobacter faecalis of each group of mice and comparison difference between groups at the same time point have no statistical significance, which indicates that the mixed probiotic powder has no influence on the amount of enterobacter intestinal tract of mice.
From table 10, it can be seen that the number of live clostridium perfringens in the intestinal tract of the mouse is changed, and the number of live clostridium perfringens in the intestinal tract of the mouse is significantly lower than that before the experiment (0d, P is less than 0.05) on the 7 th day after the intervention of the probiotic mixed powder of the experimental group, which indicates that the probiotic mixed powder has the effect of reducing the number of clostridium perfringens in the intestinal tract of the mouse.
from Table 11, it can be seen that the ratio of Bifidobacterium enterobacter to Enterobacter enterobacter (B/E) of the mice was changed, and the B/E value of the intestinal tract of the mice in the blank control group was significantly higher than that before the experiment (0d, P < 0.05) at 7 days after the experiment; after the probiotic mixed powder is intervened for 14 days in the experimental group, the B/E value of the intestinal tract of the mouse is obviously higher than that of a blank control group and a positive control group (P is less than 0.05), and the probiotic mixed powder can enhance the colonization resistance of intestinal microorganisms of the mouse and has the potential of regulating the intestinal flora.
In conclusion, the animal evaluation test data of the effect of the probiotic mixed powder on regulating the intestinal flora shows that the probiotic mixed powder can increase the number of bifidobacteria and lactobacilli in intestinal tracts of mice and reduce the number of clostridium perfringens. The B/E value is the ratio of the number of bifidobacteria to the number of enterobacteria, and this indicator can be used to evaluate the resistance of the organism to colonization of the intestinal tract by foreign microorganisms. The bifidobacterium is a representative of beneficial bacteria in the intestinal tract, the enterobacteria is considered as a predictive factor for the transformation of the intestinal flora to a harmful effect direction, the ratio of the bifidobacterium to the enterobacteria can reflect the structure of the intestinal flora in a beneficial and harmful way, after the intervention of the probiotic mixed powder of the experimental group for 14 days, the B/E value of the intestinal tract of the mouse is obviously higher than that of a blank control group, which shows that the probiotic mixed powder of the experimental group can enhance the resistance of the intestinal tract of the mouse to the colonization of external harmful microorganisms and has a beneficial regulation effect on the intestinal flora.
Example 2
The total nutrient formula powder comprises the following components in percentage by mass as shown in table 12:
TABLE 12
Name of raw materials | The product addition amount is g/100g |
Maltodextrin | 36.39 |
Deeply hydrolyzed whey protein | 25.04 |
Safflower seed oil microcapsule powder | 10.824 |
Linseed oil microcapsule powder | 3.956 |
Fish oil microcapsule powder | 5 |
Medium chain triglyceride microcapsule powder | 5.56 |
Fructo-oligosaccharide | 5.23 |
Mineral premix | 5.5 |
Vitamin premix | 1.5 |
Probiotic mixed powder | 1 |
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, weighing the raw materials according to the formula amount shown in table 12 for later use (the components of the mineral premix and the vitamin premix are the same as those in example 1);
step S20: premixing, namely putting 25.04 parts of deeply hydrolyzed whey protein (hydrolysis degree of 38%) and 36.39 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: total mixing, namely adding 10.824 parts of safflower seed oil microcapsule powder, 5.23 parts of fructo-oligosaccharide, 1.5 parts of vitamin premix, 5.56 parts of medium chain triglyceride microcapsule powder, 5 parts of fish oil microcapsule powder, 5.5 parts of mineral premix, 3.956 parts of linseed oil microcapsule powder and 1 part of probiotic mixed powder into the premixed powder in sequence, and then putting the materials into a 800L hopper to be mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
Example 3
The total nutrient formula powder comprises the following components in percentage by mass as shown in Table 13:
watch 13
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, weighing the raw materials according to the formula amount shown in table 13 for later use (the components of the mineral premix and the vitamin premix are the same as those in example 1);
step S20: premixing, namely putting 25.04 parts of deeply hydrolyzed whey protein (the hydrolysis degree is 30%) and 36.39 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: total mixing, namely adding 10.824 parts of safflower seed oil microcapsule powder, 5.23 parts of fructo-oligosaccharide, 1.5 parts of vitamin premix, 10.56 parts of medium chain triglyceride microcapsule powder, 5.5 parts of mineral premix, 3.956 parts of linseed oil microcapsule powder and 1 part of probiotic mixed powder into the premixed powder in sequence, and then putting the materials into a 800L hopper to be mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
Example 4
The total nutrient formula powder comprises the following components in percentage by mass as shown in table 14:
TABLE 14
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, weighing the raw materials according to the formula amount shown in table 14 for standby (the components of the mineral premix and the vitamin premix are the same as those in example 1);
step S20: premixing, namely putting 25.04 parts of deeply hydrolyzed whey protein (hydrolysis degree of 38%) and 36.39 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: total mixing, namely adding 11.824 parts of sunflower seed oil microcapsule powder, 5.23 parts of fructo-oligosaccharide, 1.5 parts of vitamin premix, 10.56 parts of medium chain triglyceride microcapsule powder, 5.5 parts of mineral premix, 2.956 parts of linseed oil microcapsule powder and 1 part of probiotic mixed powder into the premixed powder in sequence, and then putting the materials into a 800L hopper to be mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
Example 5
The total nutrient formula powder comprises the following components in percentage by mass as shown in table 15:
watch 15
Name of raw materials | The product addition amount is g/100g |
Maltodextrin | 47.5 |
Deeply hydrolyzed whey protein | 20 |
Sunflower seed oil microcapsule powder | 8 |
Linseed oil microcapsule powder | 5 |
Medium chain triglyceride microcapsule powder | 8 |
Fructo-oligosaccharide | 4.5 |
Mineral premix | 4 |
Vitamin premix | 1 |
Probiotic mixed powder | 2 |
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, weighing the raw materials according to the formula amount shown in table 15 for standby (the components of the mineral premix and the vitamin premix are the same as those in example 1);
step S20: premixing, namely putting 20 parts of deeply hydrolyzed whey protein (the hydrolysis degree is 34%) and 47.5 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: the method comprises the following steps of (1) totally mixing, namely adding 8 parts of sunflower seed oil microcapsule powder, 4.5 parts of fructo-oligosaccharide, 1 part of vitamin premix, 8 parts of medium-chain triglyceride microcapsule powder, 4 parts of mineral premix, 5 parts of linseed oil microcapsule powder and 2 parts of probiotic mixed powder into premixed powder in sequence, and then putting the materials into a 800L hopper to be totally mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
Example 6
The total nutrient formula powder comprises the following components in percentage by mass as shown in table 16:
TABLE 16
Name of raw materials | The product addition amount is g/100g |
Maltodextrin | 17 |
Deeply hydrolyzed whey protein | 32 |
Sunflower seed oil microcapsule powder | 15 |
Linseed oil microcapsule powder | 5 |
Medium chain triglyceride microcapsule powder | 15 |
Fructo-oligosaccharide | 6.5 |
Mineral premix | 6 |
Vitamin premix | 3 |
Probiotic mixed powder | 0.5 |
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, weighing the raw materials according to the formula amount shown in table 16 for standby (the components of the mineral premix and the vitamin premix are the same as those in example 1);
step S20: premixing, namely putting 32 parts of deeply hydrolyzed whey protein (the hydrolysis degree is 40%) and 17 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: the method comprises the following steps of (1) totally mixing, namely adding 15 parts of sunflower seed oil microcapsule powder, 6.5 parts of fructo-oligosaccharide, 3 parts of vitamin premix, 15 parts of medium-chain triglyceride microcapsule powder, 6 parts of mineral premix, 5 parts of linseed oil microcapsule powder and 0.5 part of probiotic mixed powder into premixed powder in sequence, and then putting the materials into a 800L hopper to be totally mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
Example 7
The total nutrient formula powder comprises the following components in percentage by mass as shown in table 17:
TABLE 17
Name of raw materials | The product addition amount is g/100g |
Maltodextrin | 17 |
Deeply hydrolyzed whey protein | 32 |
Sunflower seed oil microcapsule powder | 15 |
Linseed oil microcapsule powder | 5 |
Medium chain triglyceride microcapsule powder | 14 |
Fish oil microcapsule powder | 5 |
Fructo-oligosaccharide | 4.5 |
Mineral premix | 5.5 |
Vitamin premix | 1 |
Probiotic mixed powder | 1 |
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, weighing the raw materials according to the formula amount shown in table 17 for later use (the components of the mineral premix and the vitamin premix are the same as those in example 1);
step S20: premixing, namely putting 32 parts of deeply hydrolyzed whey protein (the hydrolysis degree is 38%) and 17 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: the preparation method comprises the following steps of (1) totally mixing, namely adding 15 parts of sunflower seed oil microcapsule powder, 4.5 parts of fructo-oligosaccharide, 1 part of vitamin premix, 14 parts of medium-chain triglyceride microcapsule powder, 5 parts of fish oil microcapsule powder, 5.5 parts of mineral premix, 5 parts of linseed oil microcapsule powder and 1 part of probiotic mixed powder into premixed powder in sequence, and then putting the materials into a 800L hopper to be totally mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
Example 8
The total nutrient formula powder comprises the following components in percentage by mass as shown in table 18:
watch 18
Name of raw materials | The product addition amount is g/100g |
Maltodextrin | 44.5 |
Deeply hydrolyzed whey protein | 20 |
Sunflower seed oil microcapsule powder | 8 |
Linseed oil microcapsule powder | 2 |
Medium chain triglyceride microcapsule powder | 8 |
Fish oil microcapsule powder | 5 |
Fructo-oligosaccharide | 4.5 |
Mineral premix | 4 |
Vitamin premix | 3 |
Probiotic mixed powder | 1 |
The preparation method of the total nutrient powder comprises the following steps:
step S10: weighing, weighing the raw materials according to the formula amount shown in table 18 for standby (the components of the mineral premix and the vitamin premix are the same as those in example 1);
step S20: premixing, namely putting 20 parts of deeply hydrolyzed whey protein (the hydrolysis degree is 38%) and 44.5 parts of maltodextrin into a 800L hopper, and premixing for 5min under the condition of 12rpm to obtain premixed powder;
step S30: the method comprises the following steps of (1) totally mixing, namely adding 8 parts of sunflower seed oil microcapsule powder, 4.5 parts of fructo-oligosaccharide, 3 parts of vitamin premix, 8 parts of medium-chain triglyceride microcapsule powder, 5 parts of fish oil microcapsule powder, 4 parts of mineral premix, 2 parts of linseed oil microcapsule powder and 1 part of probiotic mixed powder into premixed powder in sequence, and then putting the materials into a 800L hopper to be totally mixed for 5min under the condition of 12rpm to obtain total mixed powder;
step S40: and (4) packaging, namely packaging (filling) the total mixed powder after the total mixed powder is inspected to be qualified, wherein the speed of a packaging machine is 15 barg/min, and then externally packaging to obtain a finished product.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.
Claims (10)
1. A full-nutrition formula powder is suitable for being aged more than or equal to 10 years, and is characterized by comprising the following raw materials in parts by weight: 20-32 parts of hydrolyzed whey protein, 14.5-34 parts of fat, 17-47.5 parts of carbohydrate, 4.5-6.5 parts of dietary fiber, 4-6 parts of mineral premix, 1-3 parts of vitamin premix and 0.5-2 parts of probiotic mixed powder;
wherein the hydrolysis degree of the hydrolyzed whey protein is 30-40%;
the strains of the probiotic mixed powder comprise bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus.
2. The nutritionally complete formula according to claim 1, wherein said hydrolyzed whey protein has a degree of hydrolysis of 34% to 38%.
3. The total nutritional formula powder according to claim 1, wherein the ratio of bifidobacterium animalis BS01, lactobacillus rhamnosus LR04 and lactobacillus acidophilus is 1:1:1, and the auxiliary material of the probiotic mixed powder is polydextrose.
4. The nutritionally complete formula according to claim 1, wherein said fat is derived from at least one of sunflower oil, safflower oil, linseed oil, medium chain triglycerides, fish oil;
the carbohydrate is maltodextrin;
the dietary fiber is fructo-oligosaccharide and/or resistant dextrin.
5. The nutritionally complete formula according to claim 4, wherein said fatty material comprises the following components:
8-15 parts of sunflower seed oil microcapsule powder, 2-5 parts of linseed oil microcapsule powder and 8-14 parts of medium-chain triglyceride microcapsule powder;
or 8-15 parts of sunflower seed oil microcapsule powder, 2-5 parts of linseed oil microcapsule powder, 4-8 parts of medium-chain triglyceride microcapsule powder and 2-6 parts of fish oil microcapsule powder;
or 8-13 parts of safflower seed oil microcapsule powder, 2.5-5.5 parts of linseed oil microcapsule powder and 8-14 parts of medium-chain triglyceride microcapsule powder;
or 8-13 parts of safflower seed oil microcapsule powder, 2.5-5.5 parts of linseed oil microcapsule powder, 4-8 parts of medium-chain triglyceride microcapsule powder and 2-6 parts of fish oil microcapsule powder.
6. The nutritionally complete formula according to claim 1, wherein said nutritionally complete formula consists of:
36.39% of maltodextrin; 25.04% of hydrolyzed whey protein; 11.824% of sunflower oil microcapsule powder; 2.956% of linseed oil microcapsule powder; 10.56% of medium chain triglyceride microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder;
or, maltodextrin 36.39%; 25.04% of hydrolyzed whey protein; 11.824% of sunflower oil microcapsule powder; 2.956% of linseed oil microcapsule powder; 5.56% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder;
or, maltodextrin 36.39%; 25.04% of hydrolyzed whey protein; 10.824% of safflower seed oil microcapsule powder; 3.956% of linseed oil microcapsule powder; 10.56% of medium chain triglyceride microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder;
or, maltodextrin 36.39%; 25.04% of hydrolyzed whey protein; 10.824% of safflower seed oil microcapsule powder; 3.956% of linseed oil microcapsule powder; 5.56% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 5.23 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1.5 percent of vitamin premix; 1% of probiotic mixed powder;
or, 47.5% maltodextrin; hydrolyzed whey protein 20%; 8% of sunflower seed oil microcapsule powder; 5% of linseed oil microcapsule powder; 8% of medium chain triglyceride microcapsule powder; 4.5 percent of fructo-oligosaccharide; 4% of mineral premix; 1% of vitamin premix; 2% of probiotic mixed powder;
or, maltodextrin 17%; 32% of hydrolyzed whey protein; 15% of sunflower seed oil microcapsule powder; 5% of linseed oil microcapsule powder; 15% of medium chain triglyceride microcapsule powder; 6.5 percent of fructo-oligosaccharide; 6% of mineral premix; 3% of vitamin premix; 0.5 percent of probiotic mixed powder;
or, maltodextrin 17%; 32% of hydrolyzed whey protein; 15% of sunflower seed oil microcapsule powder; 5% of linseed oil microcapsule powder; 14% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 4.5 percent of fructo-oligosaccharide; 5.5 percent of mineral premix; 1% of vitamin premix; 1% of probiotic mixed powder;
or, maltodextrin 44.5%; hydrolyzed whey protein 20%; 8% of sunflower seed oil microcapsule powder; 2% of linseed oil microcapsule powder; 8% of medium chain triglyceride microcapsule powder; 5% of fish oil microcapsule powder; 4.5 percent of fructo-oligosaccharide; 4% of mineral premix; 3% of vitamin premix; 1% of probiotic mixed powder.
7. The nutritionally complete formula powder according to claim 1, wherein said vitamin premix consists of the following components:
maltodextrin 31.7% -68.208%; 20% -39% of choline bitartrate; 3% -10% of inositol; 3% -8% of L-carnitine tartrate; 3.5 to 7.5 percent of sodium ascorbate; 1% -4% of taurine; 0.8% -2.8% of vitamin E (50%); 0.1% -0.9% of nicotinamide; 0.1 to 0.6 percent of vitamin A acetate; 0.05 to 0.5 percent of D-calcium pantothenate; vitamin D3(cholecalciferol) 0.05% -0.5%; vitamin B12Cyanocobalamin (0.1% in maltodextrin) 0.05% -0.5%; folic acid (10% maltodextrin) 0.05% -0.5%; 0.05% -0.45% of D-biotin (1% in maltodextrin); vitamin B10.02% -0.45% of thiamine hydrochloride; vitamin B6(pyridoxine hydrochloride) 0.01% -0.45%; vitamin B2(riboflavin) 0.01% -0.45%; vitamin K1(5%) 0.001% -0.35%; potassium iodide (10% in maltodextrin) 0.001% -0.35%.
8. The nutritionally complete formula as in claim 1, whereinThe vitamin premix consists of the following components: 52.7275% of maltodextrin; 25.6078% of choline bitartrate; 6.3333% of inositol; 4.8851% L-carnitine tartrate; sodium ascorbate 4.2442%; taurine 2.0000%; vitamin E (50%) 1.7880%; 0.4563% of nicotinamide; 0.3282% of vitamin A acetate; 0.2802% of D-calcium pantothenate; vitamin D3(cholecalciferol) 0.2400%; vitamin B12Cyanocobalamin (0.1% in maltodextrin) 0.2133%; folic acid (10% maltodextrin) 0.2133%; d-biotin (1% in maltodextrin) 0.1887%; vitamin B1(thiamine hydrochloride) 0.1310%; vitamin B6(pyridoxine hydrochloride) 0.1220%; vitamin B2(riboflavin) 0.1000%; vitamin K1(5%) 0.0800%; 0.0610% potassium iodide (10% in maltodextrin).
9. The nutritionally complete formula according to claim 1, wherein said mineral premix consists of:
15% -22% of monopotassium phosphate; 15% -21% of calcium carbonate; 15% -21% of sodium chloride; 1.2% -35.68% of maltodextrin; 10 to 17 percent of magnesium sulfate (dry product); 9% -15% of potassium citrate-monohydrate; potassium pyrophosphate 0.1% -1%; manganese sulfate-water (10% in maltodextrin) 0.08% -0.45%; 0.06% -0.35% of zinc sulfate monohydrate; sodium selenite (1% in maltodextrin) 0.05% -0.6%; 0.03 to 0.4 percent of copper sulfate.
10. The nutritionally complete formula according to claim 1, wherein said mineral premix consists of:
potassium dihydrogen phosphate 18.7636; 18.6168% of calcium carbonate; 18.4612% of sodium chloride; 16.4669% of maltodextrin; 13.6567% magnesium sulfate (dried product); potassium citrate-12.7481% monohydrate; 0.4800% of potassium pyrophosphate; 0.2467% manganese sulfate-water (10% in maltodextrin); 0.2395% of zinc sulfate monohydrate; 0.1991% sodium selenite (1% in maltodextrin); 0.1212 percent of copper sulfate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011388124.3A CN112535283A (en) | 2020-12-01 | 2020-12-01 | Total nutrient formula powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011388124.3A CN112535283A (en) | 2020-12-01 | 2020-12-01 | Total nutrient formula powder |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112535283A true CN112535283A (en) | 2021-03-23 |
Family
ID=75015474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011388124.3A Pending CN112535283A (en) | 2020-12-01 | 2020-12-01 | Total nutrient formula powder |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112535283A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113317494A (en) * | 2021-06-03 | 2021-08-31 | 浙江益元素食品有限公司 | Total nutrient formula powder and preparation method and application thereof |
CN113397164A (en) * | 2021-07-02 | 2021-09-17 | 海南天壮营养工程有限公司 | Special medical full-nutrition formula food for improving immunity and preparation method thereof |
CN113598364A (en) * | 2021-08-12 | 2021-11-05 | 海南天壮营养工程有限公司 | Special medical-use total-nutrient formula food for patients with hematopathy |
CN113729211A (en) * | 2021-08-04 | 2021-12-03 | 北京斯利安健康科技有限公司 | Composition and preparation method and application thereof |
CN113925170A (en) * | 2021-09-26 | 2022-01-14 | 南昌大学 | Bean-based formula powder with anti-fatigue and immunity-improving functions and preparation method thereof |
CN113951411A (en) * | 2021-08-31 | 2022-01-21 | 国药一心制药有限公司 | Formula and preparation process of composite whey protein solid beverage |
CN114468063A (en) * | 2021-12-28 | 2022-05-13 | 上海交通大学医学院 | Fatty acid balanced type formula food with special medical application and preparation method thereof |
CN115053929A (en) * | 2022-05-23 | 2022-09-16 | 江西人之初乳品营养有限公司 | Formula milk powder suitable for people with fatty liver and preparation method thereof |
CN115137064A (en) * | 2022-07-14 | 2022-10-04 | 浙江益元素营养科技有限公司 | Total nutrient formula food for predigestion special medical application and preparation method |
CN115137063A (en) * | 2022-07-14 | 2022-10-04 | 浙江益元素营养科技有限公司 | Special medical-use total-nutrient formula food for predigested protein and preparation method |
CN115251373A (en) * | 2022-08-12 | 2022-11-01 | 中科爱伽(天津)医用食品有限公司 | Special dietary food for controlling weight, preparation process and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107951015A (en) * | 2017-12-29 | 2018-04-24 | 北京康爱营养科技股份有限公司 | Full nutrient formulation powder and preparation method thereof |
CN108294302A (en) * | 2018-01-30 | 2018-07-20 | 贵州中科金玖生物技术有限公司 | A kind of full nutrient formulation powder, preparation method and its product |
CN111657497A (en) * | 2020-06-28 | 2020-09-15 | 深圳市捷利康生物科技有限公司 | Ketogenic diet for resisting food protein allergy and preparation method thereof |
-
2020
- 2020-12-01 CN CN202011388124.3A patent/CN112535283A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107951015A (en) * | 2017-12-29 | 2018-04-24 | 北京康爱营养科技股份有限公司 | Full nutrient formulation powder and preparation method thereof |
CN108294302A (en) * | 2018-01-30 | 2018-07-20 | 贵州中科金玖生物技术有限公司 | A kind of full nutrient formulation powder, preparation method and its product |
CN111657497A (en) * | 2020-06-28 | 2020-09-15 | 深圳市捷利康生物科技有限公司 | Ketogenic diet for resisting food protein allergy and preparation method thereof |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113317494A (en) * | 2021-06-03 | 2021-08-31 | 浙江益元素食品有限公司 | Total nutrient formula powder and preparation method and application thereof |
CN113397164A (en) * | 2021-07-02 | 2021-09-17 | 海南天壮营养工程有限公司 | Special medical full-nutrition formula food for improving immunity and preparation method thereof |
CN113729211A (en) * | 2021-08-04 | 2021-12-03 | 北京斯利安健康科技有限公司 | Composition and preparation method and application thereof |
CN113598364A (en) * | 2021-08-12 | 2021-11-05 | 海南天壮营养工程有限公司 | Special medical-use total-nutrient formula food for patients with hematopathy |
CN113951411A (en) * | 2021-08-31 | 2022-01-21 | 国药一心制药有限公司 | Formula and preparation process of composite whey protein solid beverage |
CN113925170A (en) * | 2021-09-26 | 2022-01-14 | 南昌大学 | Bean-based formula powder with anti-fatigue and immunity-improving functions and preparation method thereof |
CN114468063A (en) * | 2021-12-28 | 2022-05-13 | 上海交通大学医学院 | Fatty acid balanced type formula food with special medical application and preparation method thereof |
CN115053929A (en) * | 2022-05-23 | 2022-09-16 | 江西人之初乳品营养有限公司 | Formula milk powder suitable for people with fatty liver and preparation method thereof |
CN115053929B (en) * | 2022-05-23 | 2024-04-23 | 江西人之初乳品营养有限公司 | Formula milk powder suitable for fatty liver people and preparation thereof |
CN115137064A (en) * | 2022-07-14 | 2022-10-04 | 浙江益元素营养科技有限公司 | Total nutrient formula food for predigestion special medical application and preparation method |
CN115137063A (en) * | 2022-07-14 | 2022-10-04 | 浙江益元素营养科技有限公司 | Special medical-use total-nutrient formula food for predigested protein and preparation method |
CN115251373A (en) * | 2022-08-12 | 2022-11-01 | 中科爱伽(天津)医用食品有限公司 | Special dietary food for controlling weight, preparation process and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112535283A (en) | Total nutrient formula powder | |
CN104256595B (en) | A kind of many polymerizers of whole protein type enteral nutrition | |
CA2532472C (en) | Infant or follow-on formula | |
CN108029768A (en) | A kind of baby formula milk powder containing lactoferrin and probiotics and preparation method thereof | |
CN108244252A (en) | Probiotics multielement protein powder and preparation method thereof | |
JP5864676B2 (en) | Composition for preventing or treating anemia | |
CN108522655A (en) | The baby milk and preparation method of micro functional active components in a kind of across-the-board regulation formula | |
CN110754655A (en) | Low-fat type total nutrient formula and preparation method thereof | |
CN113397164A (en) | Special medical full-nutrition formula food for improving immunity and preparation method thereof | |
CN107712050A (en) | One kind addition sialic acid and digestible premature labor baby milk powder and preparation method thereof | |
ES2803175T3 (en) | Dietary supplement | |
CN109169916A (en) | A kind of puerpera's nutriment and its production technology | |
CN111657497A (en) | Ketogenic diet for resisting food protein allergy and preparation method thereof | |
CN109156535A (en) | A kind of maternal nutritional product and its production technology | |
CN108450938A (en) | A kind of fat reducing meal replacement powder and preparation method thereof | |
CN110881526A (en) | Composition for promoting iron absorption and application thereof | |
CN110214941A (en) | A kind of full nutrition special medicine purposes formula nutritional powder of adult and preparation method thereof | |
CN112868803A (en) | Formula milk powder for improving breast milk nutrition and preparation method thereof | |
Pampaloni et al. | Parmigiano Reggiano cheese and bone health | |
CN112136894A (en) | Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof | |
CN108669563A (en) | A kind of composition, its application and strengthen immunity, the product for improving allergy | |
WO2024149132A1 (en) | Probiotic protein multivitamin and preparation method therefor | |
Koletzko et al. | Nutritional challenges of infants with cystic fibrosis | |
CN109156530A (en) | A kind of diatery supplement nutrition packet and its production technology | |
CN109527543A (en) | A kind of probiotic type hypoglycemia patient homogenate diet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210323 |
|
RJ01 | Rejection of invention patent application after publication |